Dihydrolipoyl Transacetylase (DLAT) Peptide
Aperçu rapide pour Dihydrolipoyl Transacetylase (DLAT) Peptide (ABIN8098898)
Antigène
Source
Application
-
-
Fonction
- DLAT Peptide
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Commentaires
-
This is a synthetic peptide designed for use in combination with anti-DLAT antibody ( ARP41994_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- DLAT (Dihydrolipoyl Transacetylase (DLAT))
-
Sujet
-
Background Information: DLAT is dihydrolipoamide acetyltransferase, the E2 subunit of the mammalian pyruvate dehydrogenase complex of the inner mitochondrial membrane. Patients with primary biliary cirrhosis show autoantibodies to DLAT.The DLAT gene encodes dihydrolipoamide acetyltransferase (EC 2.3.1.12), the E2 subunit of the mammalian pyruvate dehydrogenase complex (PDC, EC 1.2.4.1) of the inner mitochondrial membrane. Patients with primary biliary cirrhosis (PBC, MIM 109720) show autoantibodies to DLAT.[supplied by OMIM].
Alternative Symbols: DLTA, PDC-E2, PDCE2
-
Poids moléculaire
- 71kDa
-
ID gène
- 1737
-
NCBI Accession
- NP_001922
-
UniProt
- P10515
Antigène
-